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Abstract The present study identified ATF3 as a novel dynamic marker for ependymal stem/progenitor cells (nestin,
vimentin and SOX2 positive) around the central canal of the neonatal or adult rat spinal cord. While quiescent ependymal cells
showed cytoplasmic ATF3 expression, during 6–24 h in vitro these cells mobilized and acquired intense nuclear ATF3 staining.
Their migratory pattern followed a centrifugal pathway toward the dorsal and ventral funiculi, reminiscent of the rostral
migratory stream of the brain subventricular stem cells. Thus, the chain cell formation was, by analogy, termed funicular
migratory stream (FMS). The FMS process preceded the strong proliferation of ependymal cells occurring only after 24 h in
vitro. Pharmacological inhibition of MAPK-p38 and JNK/c-Jun (upstream effectors of ATF3 activation) prevented the FMS
mobilization of ATF3 nuclear-positive cells. Excitotoxicity or ischemia-like conditions, reported to evoke neuronal and glial
injury, did not further enhance migration of ependymal cells at 24 h, suggesting that, at this early stage of damage, the FMS
phenomenon had peaked and that more extensive repair processes are delayed beyond this time point. ATF3 is, therefore,
useful to identify activation and migration of endogenous stem cells of the rat spinal cord in vitro.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
The ependymal region of the adult spinal cord in mammals
harbors a pool of stem and progenitor cells (SPCs) readily
activated and recruited by spinal damage (Weiss et al., 1996;
Hugnot and Franzen, 2011). Even though their adult neuro-
genesis has not been observed (Sabourin et al., 2009; Hugnot
and Franzen, 2011), the neural stem cells present in the adult
spinal cord are recruited and proliferate after spinal cord
injury (Yamamoto et al., 2001b), producing scar-forming
astrocytes and myelinating oligodendrocytes (Meletis et al.,
2008). The manipulation of endogenous spinal stem cells after
injury could represent one valid alternative to stem cell
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transplantation, since it is noninvasive and avoids the need for
immune suppression (Meletis et al., 2008). Spinal stem cells
are difficult to identify due to their heterogeneity and lack
of specific expressional markers, since the ones currently
used significantly overlap with those of mature astrocytes
(McDonough and Martínez-Cerdeño, 2012). Furthermore,
there is no specific marker to discriminate between quiescent
and activated ependymal spinal cells, or to monitor migratory
ependymal cells. Moreover, the signaling pathways and genes
controlling the spinal SPC fate in normal and pathological
conditions, remain largely unknown (Hugnot and Franzen,
2011). Brain transcription factors that regulate formation and
proliferation of neural SPCs depend on the Sox family of genes,
in particular Sox2 (Liu et al., 2013). Genomic and proteomic
technologies have recently identified Wnt/beta-catenin,
Notch, sonic hedgehog and growth factor networks as major
signaling pathways involved in maintenance, self-renewal,
proliferation and neurogenesis of the neural SPCs, and have
demonstrated cross-talk between key molecules of these
pathways and their modulations by transcription factors,
miRNA and histone modifications (Yun et al., 2010).
At variance with the wealth of brain data, transcription
factors controlling spinal cord stem cells remain incompletely
understood as they have been studied with in vitro primary
cultures, showing common expression of various homeodomain-
type (Pax6, Pax7, Nkx2.2, and Prox1) and basic helix-loop-helix
(bHLH)-type (Ngn2, Mash1, NeuroD1, and Olig2) regulatory
factors in adult and embryonic rat spinal neural progenitors
(Yamamoto et al., 2001a,b). In the course of our studies with
biomarkers of neuronal damage (Kuzhandaivel et al., 2011)
we serendipitously discovered intense immunostaining of
ependymal cells for the Activating transcription factor 3
(ATF3): this observation led us to explore its expression in
control or damage-induced protocols.
ATF3 belongs to the mammalian ATF/cAMP responsive
element-binding (CREB) protein family of the Basic Leucine
Zipper (bZIP) transcription factors (Hashimoto et al., 2002)
that generate a wide range of either repressors or activators
of transcription (Thompson et al., 2009). ATF3 is thought to
be an immediate early gene, a stress inducible gene and an
adaptive response gene, which, when activated by various
stimuli, can control cell cycle and cell death machinery
(Hunt et al., 2012). ATF3 promotes proliferation, motility
and invasiveness of certain cancer cell lines (Wang et al.,
2008; Thompson et al., 2009). ATF3 expression is normally
very low in central neurons and glia, but it is markedly
upregulated in response to injury and closely linked to
survival and regeneration of peripheral axons (Hunt et al.,
2012). Both cytoplasmic and nuclear ATF3 immunostaining
has been reported with variations related to cell type,
species, and injury state when it becomes prevalently
nuclear (Hunt et al., 2012). ATF3 is supposed to have a role
in neurite growth and regeneration (Moore and Goldberg,
2011) and it has been identified as a regulator of neuronal
survival against excitotoxic and ischemic brain damage
(Zhang et al., 2011). ATF3 knockout exacerbates inflamma-
tion and brain injury after transient focal cerebral ischemia
(Wang et al., 2012). ATF3 has no known role in neuronal
development of the intact nervous system, neither has its
expression been reported in SPCs. The present study is the
first report of ATF3 as a reliable marker of activated neuro-
progenitor cells in the rat spinal cord.
Material and methods
Animals
The experiments were performed on neonatal or adult
Wistar rats in accordance with the guidelines of the National
Institutes of Health and the Italian act D.Lgs. 27/1/92 no. 116
(implementing the European Community directives no. 86/609
and 93/88), and with approval by the SISSA ethical committee
for animal experimentation. All efforts were aimed at reducing
the number of animals used and at minimizing their suffering.
Spinal cords were dissected out from neonatal animals
under urethane anesthesia (0.2 ml i.p. of a 10% w/v
solution) with continuous superfusion with Kreb's solution
containing (in mM): NaCl, 113; KCl, 4.5; MgCl27H2O, 1;
CaCl2, 2; NaH2PO4, 1; NaHCO3, 25; glucose, 11; gassed
with 95% O2/5% CO2, pH 7.4 at room temperature, as
described previously (Mladinic et al., 2013). The adult spinal
cord was dissected out from adult pregnant females, anesthe-
tized with the 10.5% chloral hydrate, 0.4 ml/100 g i.m. and
subsequently killed by an intracardiac injection (2 ml) of
chloral hydrate.
Experimental protocols
The dissected spinal cords were immediately fixed in 4%
paraformaldehyde or maintained for preset times in Kreb's
solution at room temperature and then fixed. The p38
inhibitor SB203580 or the JNK/c-Jun inhibitor SP600125
(both from Calbiochem/Millipore, Milan, Italy) was added to
the Kreb's solution for 12 or 24 h. To induce moderate or
severe excitotoxic spinal cord injury, either 50 μM or 1 mM
kainate was added to the Kreb's solution for 1 h and then
washed out in Kreb's solution for further 24 h (this
procedure has previously been described in detail by
Taccola et al., 2008; Mladinic et al., 2013). The ischemia-
like metabolic perturbation was induced as previously
described (Taccola et al., 2008; Bianchetti et al., 2013;
Mladinic et al., 2013) by incubating the tissue for 1 h in
pathological medium (PM), namely Kreb's solution containing
10 mM H2O2, 500 µM sodium nitroprusside, lacking oxygen and
glucose, with 6.75–6.80 pH and 230–240 mOsm osmolarity.
When the spinal cord was maintained in vitro for 48–72 h, the
tissue was kept in oxygenated (95% O2/5% CO2) Eagle's basal
medium (Sigma-Aldrich, St. Louis, MI, USA) supplemented
with 0.2% fetal calf serum, 30 ng/ml 7S nerve growth factor,
10 μg/ml insulin and 0.1 mg/ml gentamycin (Mladinic, 2007).
Fluorescence immunostaining procedure
The free-floating immuno-fluorescence protocol was used
as previously described (Taccola et al., 2008; Mladinic et
al., 2013). The primary antibodies (Supplemental Table 1)
were visualized using appropriate secondary fluorescent
Alexa Fluor 488 or 594 antibodies (1:500 dilution, Invitrogen,
Carlsbad, CA, USA). Sections were stained in 1 µg/ml solution
of 4,6-diamidino-2-phenylindole (DAPI) for 20 min to visualize
cell nuclei and mounted on Superfrost Plus (Menzel-Glaser,
Braunschweig, Germany) slides. The immunostaining signal
was analyzed by Zeiss Axioskop2 microscope (Oberkochen,
Germany) or TCS SP2 LEICA confocal microscope (Wetzlar,
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Germany), using 1 μm z sectioning. The ATF-3 (C-19, sc-188)
antibody (Santa Cruz Biotech, CA, USA) has previously been
used as a reliable marker for immunostaining (Tsujino et al.,
2000; Tsuzuki et al., 2001; Zhang et al., 2012). The antibody
detected the antigen of appropriate sequence since incuba-
tion (for 2 h at room temperature prior to immunostaining)
with the specific antigenic peptide (Santa Cruz Biotech,
sc-188P; dilution 1:5) abolished staining (Supplemental
Fig. 1). Quantification of immunofluorescence signals
(gray level intensity expressed in arbitrary units, AU) was
performed with Meta-Vue imaging software (Molecular
Devices, Sunnyvale, CA, USA) using the densitometry function
to calculate mean signal intensities for areas of interest
(white rectangles) reactive to ATF3 or SOX2 (1000 μm2
covering the ependymal zone as shown in Fig. 1B for ATF3
and Fig. 4A for SOX2). The values are mean ± SD (at least
three different fields in each one of three different sections
from two different spinal cords). For each age sample,
immunostaining was performed on spinal slices from at least
two animals. At least 3 different slices were analyzed for
each spinal cord. On each slice, the intensity of the ATF3 or
SOX2 immunostaining was measured in at least 3 different
fields covering 100 μm2 large ependymal cell zone around
the central canal.
Figure 1 Age-related expression of ATF3 by spinal ependymal cell and its co-expression with nestin and vimentin immunostaining.
(A): Examples of cytoplasmic ATF3 immunostaining (red) of the ependymal region around the central canal (CC) of P2, P4, P7 and
adult rat spinal cord cross-sections (30 μm thick). (B): Higher magnification of ATF3 immunostaining (with DAPI nuclear counterstaining)
of ependymal cells in P4 spinal cord. For image clarity fluorescent stainings (left andmiddle panels) were converted to grayscale and their
negatives are shown to reveal the fibrillary, cytoplasmic ATF3 staining of ependymal cells. In right panel, ATF3 (red) and DAPI (blue)
fluorescent stainings are merged. (C): Histograms show the intensity of ATF3 immunostaining (AU) in an area of interest covering the
1000 μm2 of the ependymal zone (as shown with a white dashed rectangle in B, middle panel) from postnatal day 2, P2, until adult age.
The values aremean ± SD (at least three different fields in each one of three different sections from two different spinal cords). The data
fromP2 and adult spinal cords are significantly different from those obtained from those of P4–7 (P b 0.001; OneWay Analysis of Variance
test). (D): Higher magnification of vimentin immunostaining (green) in the ependymal zone (marked with the lower dashed rectangle in
the third panel of A) that overlaps with ATF3 staining (red) as shown by bottom panel in D. (E): Higher magnification of nestin
immunostaining (green) in processes extending from ependymal region toward the dorsal funiculus (area marked with the upper dashed
rectangle in the third panel of A) that overlaps with ATF3 staining (red) as shown by bottom panel in E. Scale bars = 50 μm (A,B) or 20 μm
(D,E). dors = dorsal side of the spinal cord; vent = ventral side of the spinal cord.
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Quantification of ATF3, Ki67 or EdUpositive cell nuclei
To analyze mobilization of stained cells, ATF3, Ki67 or
5-ethynyl-20-deoxyuridine (EdU) nuclearly labeled cells
were counted in a central spinal region (termed funicular
migratory stream, FMS; 150 μm wide) that, as shown in
Fig. 3C, included a sagittal area from the apex of the dorsal
funiculus to the apex of the ventral funiculus. The
proliferation assay Click-iT® EdU (Invitrogen) was used in
accordance with the manufacturers' instructions as recently
detailed (Mazzone et al., 2013). Thus, the spinal cords were
incubated for 6, or 24 h in Kreb's solution or for 48 h in Eagle
culture medium (see Experimental protocols) containing
EdU (10 μM), then fixed, cryopreserved and microtome-
sectioned. Incorporated EdU was detected with the fluo-
rescent azide coupling reaction. Sections were then washed
twice with 3% BSA in PBS and immunostained with ATF3 or
Ki67 antibody.
Western blotting
Cytoplasmic and nuclear fractions were separated by a
standard procedure (Kuzhandaivel et al., 2010). Quantifi-
cation of protein content was performed using a
bicinchoninic acid test. Gel electrophoresis was performed
on 12% acrylamide SDS gels. As a size standard, Page Ruler
Prestained Protein Ladder (Fisher Scientific SAS, Illkirch
Cedex, France) from 10 kDa to 170 kDa was used. As
positive control, we used RAW 264.7 Cell Lysate (sc-2211,
Santa Cruz Biotech). The membrane was incubated with
anti-ATF3 (ATF-3, C-19, sc-188, Santa Cruz Biotech) diluted
1:100 in blocking solution. For the negative control, the
primary antibody was pre-incubated with the specific
blocking peptide (Santa Cruz Biotech, sc-188P; dilution
1:5). Blots were incubated overnight at 4°C. The signal was
visualized using fluorescence-labeled secondary anti-rabbit
antibodies, produced in goat, with 1:2000 dilution (Dako
Italia, Milan, Italy). The results were acquired using Alliance
LD2-77WL (Uvitec, Cambridge, UK) and analyzed with
Uviband software (Uvitec). ATF3 levels for the cytoplasmic
fractions were normalized for β-actin using a β-Actin–
Peroxidase antibody (A3854, Sigma-Aldrich), while the
nuclear fractions were normalized for TATA binding protein
(AB62126, Abcam, Cambridge, UK).
Data analysis
All data are expressed as mean ± SD, except for the Western
blotting where the data are mean ± S.E. Statistical analysis
was carried out with SigmaStat 3.1 (Systat Software,
Chicago, IL, USA). The statistical analysis of the ATF3
immunostaining intensity measurements in spinal cords of
various aged rats was performed using One Way Analysis of
Variance test, and then, for the pairwise multiple comparison
procedures, the Tukey test was used. The number of
measurements in each group was N20 (at least two measure-
ments in each of ten different spinal cord sections from three
different animals). For the statistical comparison of the ATF3
and SOX2 immunostaining intensity measurements, the t-test
was used. The number of measurements in each group was 10
(at least three measurements in each of three different spinal
cord sections from two different animals). For the statistical
analysis of the number of cells with the ATF3, Ki67 or EdU
positive nuclei, the t-test was also used. The number of
sections on which the counting was performed ranged from 6
to 20 for each experimental protocol. For the statistical
analysis of the Western blotting ATF3 signal, data were first
assessed as parametric with a normality test (Anova Tukey)
and then analyzed with the paired and two tailed distribu-
tion Student t-test. The signals obtained from two different
blots were analyzed, and in each experiment, different
protein samples, coming from the three different animals,
were collected. Thus, the total number of animals for each
experimental group was six.
Results
Postnatal ATF3 expression in spinal ependymal cells
overlaps with nestin, vimentin and SOX2
Strong ATF3 immunostaining was detected in the cytoplasm
of ependymal cells around the spinal central canal of rats
aged from postnatal day (P) 2 up to adulthood (Fig. 1A). The
ATF3 filamentous staining in the ependymal zone is clearly
observed in Fig. 1B. The intensity of the ATF3 immunostain-
ing in the area of interest of ependymal zone (dashed
rectangle in Fig. 1B, middle) was found to increase
postnatally, and remained elevated in adulthood (Fig. 1C).
ATF3 staining overlapped with vimentin (Fig. 1D and Supple-
mental Fig. 2) and nestin (Fig. 1E and Supplemental Fig. 3),
markers expressed by stem cells of the spinal ependymal
region (Hugnot and Franzen, 2011). At neonatal age vimentin
costainedwith ATF3 in the ependymal region, while nestinwas
prevalently localized to processes extending from the
ependymal zone toward the spinal funiculi to morphologically
bisect the cord transverse plane (Supplemental Figs. 3A–B). In
the ependymal region nestin staining was weak (inset to
Supplemental Fig. 3A). As previously reported by (Mokrý et al.,
2008), in adult rats nestin stainingwas observed not only in the
ependymal region, but also in the blood vessels, while ATF3
staining remained confined to the ependymal zone (Supple-
mental Fig. 3D). Ependymal cells from embryonic and PO
tissue did not show marked ATF3 staining.
Both neonatal and adult ependymal cells were co-stained
for ATF3 and the transcription factor SOX2 (Fig. 2A). The
results for P4 and P7 age are shown in Supplemental Fig. 4.
Fig. 2B shows, at higher magnification, a central section
from a stack of z-plane confocal images of adult spinal
ependymal cells that confirmed the cytoplasmic ATF3 and
nuclear SOX2 stainings of densely packed cells.
Outside the ependymal zone, no significant ATF3 staining
was observed in the gray matter as shown by the spinal cord
cross section in the reconstructed Fig. 2C. It is noteworthy,
however, that, in the lateral and ventral regions of the white
matter, cytoplasmic ATF3 staining was detected in sparse
cells at early postnatal age (P1–P4) (Fig. 2D). In these white
matter cells (showing ramified morphology similar to the
NG2/BrdU positive cells; Horner et al., 2000), cytoplasmic
ATF3 and NG2 staining coincided with nuclear SOX2 staining
(Figs. 2D–E).
ATF3 staining in the ependymal region did not overlap
with any of the following cell-specific markers: NeuN
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(neurons), DCX (neuronal precursors and immature neurons),
GFAP (astrocytes), NG2 (oligodendrocyte precursor cells), O4
(oligodendrocytes and their precursors), or CD68 (activat-
ed microglia) (Supplemental Fig. 5). It should be noted
that the same ATF3 antibody did not revealed any
immunopositive cells in the ependymal spinal cord region
of the mouse (results not shown). It has been previously
reported that the pattern of ATF3 immunostaining is
species-specific (rat or mouse) (Hunt et al., 2012).
Furthermore, depending on neuronal type and the intra-
cellular or extracellular milieu, ATF3 may be cytoplasmic
and/or nuclear (Seijffers et al., 2006).
In vitro mobilization of ependymal spinal cord cells
and nuclear ATF3 expression
Previous studies have indicated that the spinal cord
preparation survives in vitro for at least 24 h with functional
network activity clearly observed as locomotor-like patterns
recorded from multisegmental motor pools (Kuzhandaivel et
al., 2011). Fig. 3 shows that such in vitro protocol stimulated
mobilization of ependymal cells from the central canal zone
toward the dorsal and ventral funiculi (Figs. 3B–D), creating,
at 24 h, a characteristic pattern reminiscent of the rostral
migratory stream (RMS) of the brain subventricular stem
Figure 2 ATF3 immunostaining of ependymal spinal cord cells overlaps with SOX2 in neonatal and adult rats. (A): Spinal cord
cross-sections (30 μm thick) of neonatal (top row) or adult (bottom row) spinal cord immunostained with SOX2 and ATF3. The left
panels show cell nuclei stained with DAPI (grayscale conversion). In the right panels the fluorescent signals with DAPI (blue), SOX2
(green) and ATF3 (red) are merged. (B): Central section from a stack of z-plane confocal images showing (high magnification) the
ependymal zone of adult spinal cord stained with cytoplasmic ATF3 (red), nuclear SOX2 (green) and counterstained with DAPI (blue).
(C): Half-section of the P1 spinal cross-section reconstructed from 6 different images (10×). Note that ATF3/SOX2 staining is localized
to the ependymal zone, with scattered positive cells in the white matter. (D): Higher magnification of white matter cells with ATF3
cytoplasmic staining (red) and SOX2 nuclear staining (green). (E): Higher magnification of white matter cells with NG2 cytoplasmic
staining (red) and SOX2 nuclear staining (green). Scale bar is 100 μm in A,C, 10 μm in D and 50 μm in D,E.
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Figure 3 Nuclear ATF3 immunostaining of activated, mobilized stem cells. (A–D): ATF3 immunostaining (grayscale) in 30 μm thick
sections from the central zone around the central spinal canal (CC) of P2 rat spinal cord. Note fresh tissue with fibrillar, cytoplasmic
ATF3 staining of ependymal cells (A) and nuclear ATF3 staining of cells after 24 h in vitro (B–D) demonstrating migration from the
central canal toward the dorsal and ventral spinal funiculi. (C): Half-section of the spinal cord shows the 150 μmwide zone (delimited
by red lines) through which the spinal ependymal cells migrate to form the funicular migratory stream (FMS). (D): FMS zone
(reconstructed from two images taken at 10×). (E): Grayscale conversion of ATF3 fluorescent immunostaining of P2 rat spinal cords
maintained in vitro for 0–24 h, indicating the time course of ependymal cell migration. (F): Number of cells in FMS zone with the
nuclear ATF3 staining shows migration started between 4 and 6 h in vitro, and peaked after 24 h. (G): Time-dependent occurrence of
ATF3 nuclearly-positive cells in the FMS zone (blue rectangle) 150 μm away from the central canal. Scale bar is 50 μm in A,B and D,
200 μm in C and 100 μm in E.
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cells (Coskun and Luskin, 2002; Murase and Horwitz, 2004).
By analogy, the spinal cord ependymal migration was termed
FMS (see Materials and methods), and was clearly restricted
to this 150 μm wide area (Fig. 3C, red lines). The time course
of nuclear ATF3 staining is shown in Fig. 3E, and plotted in
Fig. 3F. Thus, a detectable ATF3 nuclear signal appeared 4 h
after dissection and reached a plateau between 14 and 24 h.
Likewise, the occurrence of ATF3 positive cells in the FMS area
(indicated by the blue rectangle in Fig. 3C) had a similar time
course (Fig. 3G). The ATF3-nuclear positive migratory cells
were nestin (Supplemental Fig. 6A), vimentin (Supplemental
Fig. 6B) and SOX2 (Supplemental Fig. 6C) positive. Fig. 4A
demonstrates the differential distribution of ependymal cell
ATF3 staining that was strong around the central canal of fresh
tissue (top row in A; region of interest quantified in Fig. 4B),
whereas it significantly (P b 0.001) decreased (Fig. 4A, bottom
Figure 4 Differential ATF3 and SOX2 immunostaining in ependymal zone of P2 spinal tissue maintained in vitro. (A): Central region
of the spinal cord (30 μm thick cross-sections) stained with ATF3 (red) and SOX2 (green) and counterstained with DAPI (grayscale);
upper panels show freshly fixed tissue (FF), while lower panels show spinal cord tissue after 24 h in vitro. In right panels the ATF3
(red), SOX2 (green) and DAPI (blue) fluorescent stainings are merged. Note the fibrillary, cytoplasmic ATF3 staining in ependymal
cells of fresh tissue, which largely disappears after 24 h in vitro. By contrast, the nuclear SOX staining remains similarly intense in
fresh tissue and after 24 h in vitro. (B): Histograms of signal intensity (AU) in the area of interest of the ependymal zone indicated by
the white rectangles in (A). Note significant drop of ATF3 signal (P b 0.001) after 24 h in vitro while the SOX2 signal did not change.
Data are mean ± SD from 10 sections for each group. (C): Confocal images of DAPI (blue), SOX2 (green) and ATF3 (red) staining of
ependymal cells of the spinal cord maintained in vitro for 24 h. Bottom hatched box (A, left) indicates the ependymal region used for
confocal microscopy. Note the absence of the ATF3 immunostaining signal in (C). (D): DAPI (blue), SOX2 (green) and ATF3 (red)
staining of the region apical to the central canal, to which ATF3 nuclearly-positive cells migrate. Note nuclear ATF3 staining
overlapping SOX2 nuclear staining. Scale bar = 50 μm in A and 10 μm in C and D.
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row, and Fig. 4B) at 24 h in vitro. Figs. 4C–D compare the ATF3
expression in two areas of interest (indicated by hatched
squares in Fig. 4A, bottom left) and demonstrates that
mobilized cells (Fig. 4D) showed nuclear ATF3. On the other
hand, nuclear SOX2 staining was consistently found in cells
surrounding the central canal in fresh tissue (Fig. 4A, top row) or
after 24 h in vitro (Fig. 4A, bottom row) and remained
expressed even in the migrated cells (Figs. 4B,D). These results
suggest that, while SOX2 was a general stem cell marker, ATF3
preferentially stained nuclei of those ependymal cells under-
going mobilization.
ATF3 is widely used as a marker for axotomized motoneu-
rons (Tsujino et al., 2000), or injured dorsal root ganglion
neurons (Tsuzuki et al., 2001). The present study examined
ATF3 expression inmotoneurons at various times in vitro. ATF3
was detected in the motoneuron cytoplasm already 2 h after
dissection, reached a peak at 4 h, after which it decreased
with no nuclear staining (Supplemental Fig. 7A). Supplemental
Fig. 7B shows, in the same spinal section, strong ATF3 signal in
the FMS area (right edge) in contrast with lack of signal from
motoneurons (left edge) at 24 h in vitro. At this time point
motoneurons were well preserved as shown by their SMI32
staining (Supplemental Fig. 4C) and remain functionally
viable (Kuzhandaivel et al., 2011). These results validate
ample survival of motoneurons at 24 h in control conditions
with no nuclear ATF3 staining characteristic for the injured
motoneurons.
To assess if nuclear ATF3-positive migrating cells are able
to differentiate into neural cells, we performed double
immunostaining of ATF3 and neuron-specific markers such as
β-tubulin III and NeuN, or DCX, a neural progenitor marker,
in P2 spinal cords maintained in culture for 3 days, to allow
abundant migration of ATF3-nuclearly positive cells. Supple-
mental Fig. 8 demonstrates that ependymal migrating cells
remained negative for these markers with rare detection of
DCX positivity (arrow in Supplemental Fig. 8).
Proliferative markers of the ependymal region in vitro
The time-dependent redistribution of ATF3 stained cells might
have suggested not only mobilization, but also cell prolifera-
tion developing during a few hours in vitro. To examine this
possibility, we first investigated in the FMS selected region of
interest (see Figs. 3C, 5A–C) if cells, which had incorporated
EdU as a DNA marker of cell proliferation (Mazzone et al.,
2013) also showed ATF3 positivity at 6–48 h in vitro. When the
whole FMS region was examined, at 6 h we detected 50 ± 10
EdU positive cells and a lower number of ATF3 nuclear-positive
(Edu-negative) cells (20 ± 7; n = 6; Fig. 5D). At 24 h, while the
number of EdU positive cells in the FMS area had not changed
(52 ± 5; n = 6) vs the value at 6 h (Fig. 5D), the number of
ATF3 nuclearly-positive cells increased more than four times
(83 ± 18, n = 20). In support of this observation we also
studied the number of cells with their nucleus positive for the
proliferativemarker Ki67 (Mazzone et al., 2013). Fig. 5D shows
a similar number of Ki67 or ATF3 positive nuclei at 24 h in the
entire FMS region, whereas when the tissue was kept in Eagle
culture medium for 48 h, ATF3 staining grew vs Ki67 staining
(double immunostaining with Ki67 and ATF3 was not possible
for lack of compatible antibodies). Fig. 5C (arrows) also
depicts the occurrence of ATF3 and EdU co-staining after 48 h
in vitro in the ependymal area. Such ATF3 and EdU double-
positive nuclei account for 6.1% ± 1.77 (n = 10) of the total
number of ATF3 nuclei in the FMS region. Fig. 5E shows the
slow increase in the number of ATF3 and Edu double-positive
nuclei over time in culture (6–48 h). Thus, our results suggest
that ATF3 nuclearly-stained cells migrated away from the
central canal with a time profile distinct from local cell
proliferation.
Signaling pathways underlying ATF3 activation
ATF3 activation has been previously shown to be dependent
on c-Jun phosphorylation (Lindwall et al., 2004) or the
mitogen-activated protein kinases (MAPK)/p38 pathway (Lu et
al., 2007). In keeping with this notion, the MAPK-p38 inhibitor
SB203580 or the JNK/c-Jun inhibitor SP600125 prevented the
rise in the number of ATF3 nuclear-positive cells in the FMS
region at 12 h in vitro (Figs. 6A,B). In fact, application of
SB203580 (1 μM) or SP600125 (50–100 μM) treatment (12 h)
led to absence of nuclear ATF3 signal that was replaced by
filament-like, cytoplasmic staining (Fig. 6A).
We next investigated ATF3 protein levels in the nuclear and
cytoplasmic extracts from freshly frozen spinal tissue, or
maintained for 24 h in Kreb's solution (with or without
SB203580 or SP600125). To this end, we used the same
anti-ATF3 antibody used for immunostaining previously validat-
ed to detect ATF3 protein by Western blotting in cancer tissue
(Buganim et al., 2011). The 22 kDa band, corresponding to the
full-length ATF3 (Hashimoto et al., 2002; Buganim et al., 2011;
Chen et al., 1994), was of the highest intensity in nuclear
lysates (loading control was TBP) from spinal tissue maintained
in vitro for 24 h (sham; Fig. 6C, top lane, and Fig. 6D), very low
from fresh tissue, and significantly (P N 0.01) weaker 24 h after
SB203580 (1 μM) or SP600125 (100 μM) treatment (Figs. 6C,D).
As a positive control, the lysate from RAW 264.7 cells (Abelson
murine leukemia virus-induced tumor) was employed, as
suggested by the ATF3 antibody manufacturer (see Fig. 6C,
right lanes), to produce a strong ATF3 band. Thus, the change in
the intensity of the ATF3 specific nuclear expression mirrored
the pattern of the ATF3 immunofluorescence signal observed
in the nuclei of mobilized cells. Regardless of the protocol
used, a band of 28 kDa (as reported by the ATF3 antibody
manufacturer) was observed with unchanged intensity in
cytoplasmic lysates (β-actin loading control; Fig. 6C, lower
lanes).
ATF3 activation after experimental SCI
We recently reported that in vitro spinal cord lesions like
excitotoxic injury (Mazzone et al., 2013) or oxygen-glucose
deprivation (Bianchetti et al., 2013) applied for a short time
(1 h), induce a slowly developing process of cell death that
peaks at 24 h. We, therefore, wondered if these paradigms
could activate ependymal cell early mobilization. Fig. 7A
shows the presence of ATF3 positive cells in the FMS area
24 h after 50 μM kainate application (1 h). Likewise, Fig. 7B
depicts, in the same region, ATF3-positive cells 24 h
following ischemic-like injury (1 h application of a patho-
logical medium lacking oxygen and glucose and containing
reactive oxygen species; Bianchetti et al., 2013). Such cells,
with ATF3 positive nuclear staining, were also nestin and
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vimentin positive (Figs. 7A,B). Fig. 7D shows that, with
either protocol, the number of cells with the ATF3 positive
nucleus in the FMS area was similar to control at 24 h in vitro.
Only when the concentration of kainate was raised to 1 mM to
apply a very intense excitotoxic stimulus, did the number of
ATF3-nuclear positive cells significantly (P = 0.005) fall by
one-third, suggesting substantial cell loss (Figs. 7C,D).
Discussion
The current study is the first report of the dynamic
expression of ATF3 by ependymal spinal stem cells, as this
protein was localized to the cytoplasm when such cells were
quiescent, but was found in their nucleus when cells became
activated. This property enabled us to follow up activated
ependymal cells that migrated from the central canal
toward the ventral and dorsal white matter, forming the
FMS that resembles the RMS of the brain SPCs. The fact that
ATF3 immunostaining coincided with well-known SPC
markers, such as nestin, vimentin and SOX2, suggests that
ATF3 labeling in the spinal cord was primarily expressed by
intrinsic stem cells, typically found around the central canal
(Hugnot and Franzen, 2011). ATF3 was mainly expressed in
the cytoplasm and processes of these cells from P1 onwards,
grew during the first postnatal week and remained elevated
later. Such ATF3 stained cells in fresh tissue had small
diameter, large egg-shaped nucleus, and were closely packed
Figure 5 Proliferative cells in funicular migratory stream (FMS). (A,B,C): Nuclear co-immunostaining of ATF3 (red) and EdU (green)
in spinal section (30 μm thick) of spinal cord maintained in vitro for 6 h (A), 24 h (B) or 48 h (C). The labeled cells belong to the FMS,
the borders of which are denoted by dashed lines in C. Note that the green EdU signal does not overlap with ATF3 positive nucleus in A
and B. In C the ATF3/EdU positive cells are marked with arrows. Scale bar = 50 μm. CC = central canal. (D): Histograms showing
number of EdU, ATF3 or Ki67 positive nuclei in FMS region of spinal cords maintained in vitro for 6, 24 or 48 h. Note the steady number
of proliferative EdU or Ki67 positive cells and significant increase in ATF3 positive nuclei after 24 or 48 h in vitro (***P ≤ 0.001 for
ATF3; n = 6–20 sections from 3 spinal cords). (E): Histogram shows number of ATF3 and Edu double-positive nuclei in FMS region of
spinal cords maintained in vitro for 6, 24 or 48 h (n = 3–10 sections from 3 spinal cords).
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together. Gray matter cells remained, however, devoid of
ATF3 staining, adding specificity to the role of this protein for
stem cell labeling.
Previous reports of the role of ATF3 in the regulation of
SPCs are scant. Recent studies (Gao et al., 2013; Gargiulo
et al., 2013) have indicated involvement of ATF3 in the
control of genes like SOX2 or BMI1, critical for pluripotency
and reprogramming of the human embryonic stem cells or
glioblastoma stem-like cells. The present observation of
ATF3 and SOX2 co-staining is consistent with this possibility.
Moreover, the CREB transcription factor family, of which the
ATF3 is a member, has an established role in SPC regulation
and neurogenesis (Merz et al., 2011; Mantamadiotis et al.,
2012). Our results suggest, however, a new role of ATF3 not
only in the maintenance of the spinal ependymal cells but also
in their activation.
When spinal cords were kept in vitro for 24 h, we
observed a novel phenomenon, namely centrifugal mobili-
zation of ependymal stem cells which formed a migratory
chain analogous to the brain RMS (Lois et al., 1996;
Wichterle et al., 1997; Tanvig et al., 2009) as they moved
away from the central canal to the adjacent ventral and
dorsal white matter. When this occurred, ATF3 was clearly
expressed in the cell nucleus. This phenomenon developed
gradually after 4 h and was fully observed at 24 h.
Interestingly, ependymal cells which did not mobilize,
retained their SOX2 nuclear staining, yet lost the ATF3
cytoplasmic one. Hence, ATF3 nuclear labeling could be
interpreted as a novel marker of migrating ependymal cells.
The fact that in vitro conditions induce mobilization of stem
cells has been earlier reported with organotypic brain slices
(Tanvig et al., 2009): in such a case RMS toward the olfactory
bulb is occurring after several days, while the present report
shows a much faster process developing within hours. Our
proposal of RMS-like migration is currently based on morpho-
logical observations only, since these cells did not stain for
NCAM, typical marker of RMS in the olfactory bulb (Hu et al.,
1996). Thus, we suggest that the unchanged occurrence of
Ki67 or EdU positive cells in FMS at 24 h in vitro is compatible
with a process of ependymal cell early mobilization rather
than proliferation. In support of this hypothesis is the recent
observation that, in rat organotypic slices, significant prolif-
eration of neuroprogenitors was detected only after several
days in culture (Mazzone et al., 2013). We cannot exclude that
ATF3-positive cells might eventually become neurons and/or
glia and integrate into spinal networks. This possibility would
Figure 6 The p38 inhibitor SB203580 or the JNK/c-Jun inhibitor SP600125 blocks nuclear ATF3 staining in spinal cords after 24 h in
vitro. (A): Control ATF3 immunostaining (grayscale) in the region near the central canal (CC) after 12 h in Kreb's solution (left, sham;
note the intense nuclear ATF3 staining), after treatment with the p38 inhibitor SB203580, or the JNK/c-Jun inhibitor SP600125 for the
12 h. Note filamental ATF3 staining (middle and right panels). Scale bar = 50 μm. (B): Number of cells with nuclear ATF3 staining in
the FMS region (delineated with red lines in Fig. 3C) are plotted to show inhibition of cell occurrence after SB203580 or SP600125
treatment (n = 6–20 sections from 3 spinal cords for each condition). (C): Western blots show ATF3 in the nuclear (upper band) and
cytoplasmic (lower band) protein fractions from the freshly frozen tissue (FF) or the tissue maintained in vitro for 24 h with or without
(SHAM) SB203580 or SP600125 inhibitors. As a positive control, the lysate from RAW 264.7 cells (Abelson murine leukemia virus-induced
tumor) is used and the negative control is the result obtained after incubating the ATF3 antibody with the specific blocking peptide prior
to immunostaining in the Western blot. The loading control for the cytoplasmic fractions was β-actin and for the nuclear fractions TATA
binding protein (TBP). The data were collected from different gels, as indicated by black boxes. (D): Intensity of 22 kDa band ATF3 is of
the highest value in nuclear lysates from spinal tissue maintained in vitro for 24 h, when compared to fresh tissue or the tissue treated
with the inhibitors (P N 0.01; data are duplicate experiments for 6 spinal cords for each condition).
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assume a delayed maturation process outlasting our observa-
tion period limited by tissue survival, and actually absent in
spinal slice culture (Mazzone et al., 2013).
The question then arises regarding the mechanism(s)
responsible for activation and mobilization of ependymal
cells in vitro, given that spinal networks are fully preserved
and viable during this timeframe, including electrophysio-
logical activity of locomotor networks (Taccola et al., 2008).
In vivo the ependymal cells are in direct contact with the
cerebrospinal fluid (CSF) and numerous blood vessels (Hugnot
and Franzen, 2011). Thus, their delayed activation in vitro
might be due to the disappearance of yet-unclear signals from
the CSF or blood (Menezes et al., 2002), which would normally
keep the ependymal cells quiescent (Cheung and Rando,
2013). Additionally, the activating signal might come from a
few cells injured during dissection, even if systematic analysis
of in vitro tissue showed minimal pyknosis at 24 h in vitro
(Taccola et al., 2008). A recent review has highlighted how
stem cell quiescence is a state maintained by signaling
pathways ready to allow rapid activation (Cheung and Rando,
2013). Deciphering the molecular mechanisms regulating stem
cell quiescence is, therefore, an important goal for future
studies to increase our understanding of tissue regeneration
mechanisms in pathological conditions (Cheung and Rando,
2013). Identification of the factors underlying even brain RMS
remains incomplete as various chemo-attractants, chemo-
repellents, growth factors and cell adhesion molecules have
been proposed to guide migrating cells (Menezes et al., 2002;
Tanvig et al., 2009). The intracellular presence of other ATF/
CREB family members with which ATF3 forms heterodimers
may ultimately decide the functional role of ATF3 (Thompson
et al., 2009), as much as the influence of regulators like other
transcription factors, miRNA or histone modifications (Yun et
al., 2010). Future studies are necessary to determine if the FMS
pattern of migration detected in vitro appears also in vivo or is
due to the experimental tissue preparation with absence of
cues from CSF and blood vessels, and if this phenomenon is
observed in adult animals as well.
Previous studies have demonstrated that the signal
transduction pathways mediating ATF3 expression include
c-Jun co-expressed with ATF3 in the nervous system after
injury and stress (Hunt et al., 2012). The selective JNK/
c-Jun inhibitor SP600125 fully blocks ATF3 induction in adult
rat ganglion neurons and inhibits outgrowth of their axons
(Lindwall et al., 2004). Furthermore, the MAPK/p38 pathway
is also required for ATF3 expression in several non-neuronal
cell lines undergoing apoptosis, an effect suppressed by the
specific MAPK/p38 inhibitor SB203580 (Lu et al., 2007). In
accordance with these results, our current data showed the
involvement of both molecular pathways (JNK/c-Jun and
MAPK/p38) in the control of the ATF3 nuclear expression in
mobilized spinal ependymal cells. This observation was also
supported by Western blotting analysis indicating ATF3
expression (of molecular weight in full accord with reports
by Chen et al., 1994; Hashimoto et al., 2002) in nuclear
fractions at 24 h in vitro. The origin of the variation in the
molecular weight between the nuclear and cytoplasmic
ATF3 protein remains unclear and will need future work.
Excitotoxic or ischemic-like protocols, that are reported
to produce moderate damage to the spinal cord (Taccola et
al., 2008; Mazzone et al., 2010; Bianchetti et al., 2013), did
not enhance the number of activated and migrating ATF3
positive cells 24 h later. When the excitotoxic stimulus was
very strong (1 mM kainate), the number of activated
ependymal cells actually decreased in line with widespread
neurotoxicity (Taccola et al., 2008). Our previous investiga-
tions have indicated that, in the rat spinal cord, neuronal
and glial death occurs mainly during the first 24 h (Taccola
et al., 2008; Bianchetti et al., 2013; Mazzone et al., 2013).
Any attempt to repair cell damage might perhaps require an
intervention by stem cells occurring over several days after
the primary injury. This process has been examined with
long-term organotypic cultures in which stem cell activation
two weeks after excitotoxic stimulation failed to produce
significant neurogenesis (Mazzone et al., 2013). While ATF3 is
reported as a marker for the axotomy-dependent motoneuro-
nal injury in the rat (Zhang et al., 2012), we detected
transient, rather early cytoplasmic (never nuclear) staining
for ATF3 in motoneurons, a phenomenon that disappeared
by 24 h in vitro. Our data, thus, confirm that maintaining
the rat spinal cord in vitro did not per se lead to neuron
Figure 7 ATF3 positive cells after excitotoxic or ischemia-like
spinal injury. (A): ATF3 (red) and nestin (green) double staining of
FMS region around the central canal of 30 μm thick sections of
spinal cord 24 h after exposure to moderate (1 h long) excitotoxic
injury with 50 μM kainate. (B): similar experiment as in A using
ATF3 and vimentin co-staining, although the toxic stimulus was 1 h
application of pathological medium (PM) mimicking ischemia
conditions. (C): very strong excitotoxic stimulus with 1 mM kainate
leads to decreased ATF3 signal in the FMS region. (D): The number
of the cells with nuclear ATF3 staining in the FMS region (delineated
with red lines in Fig. 3C) is significantly (P = 0.005) smaller in 1 mM
kainate treated spinal cords with 1 mM kainate (n = 6–20 sections
from at least 3 spinal cords for each group).
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damage as clearly indicated by fully preserved network
responses (Taccola et al., 2008) and that ependymal cell
mobilization was probably a reaction to changes in the
extracellular milieu.
We propose that the role of ATF3 might be different in
the neuronal (postmitotic) and ependymal (mitotic) spinal
cells. In neurons ATF3 is viewed as a late marker for injury
(Tsujino et al., 2000; Tsuzuki et al., 2001; Francis et al., 2004),
with a neuroprotective and pro-survival influence (Zhang et
al., 2011; Wang et al., 2012).
Conclusions
In lower vertebrates the spinal cord can regenerate after
injury, a process in which ependymal cells play a major role
(Hugnot and Franzen, 2011). The mammalian spinal cord,
however, cannot regenerate after lesion: hence, intense efforts
are in progress to develop new, noninvasive, endogenous-stem
cells based strategies for the treatment of spinal injury
(Barnabé-Heider and Frisén, 2008; Sahni and Kessler, 2010;
Ruff et al., 2012). The discovery of ATF3 as a marker not only
for quiescent but particularly for activated, migrating spinal
SPCs should help future work to monitor their migration and
fate (neurogenesis or gliogenesis) after injury and to test drugs
to change the outcome. One might even imagine that it would
be possible to up-regulate the ATF3 gene in ependymal spinal
cells after injury to find out their impact on the neuronal
tissue repair.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.03.006.
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